Listed on GrantGunner. Last checked 28 Sep 2026.
About this grant
This is a rolling program that supports Japanese MedTech startups entering the U.S. market with regulatory, intellectual property, business development, and investor connections. It targets Japanese companies from Seed to Late-stage that have an MVP, English capability, and intent to enter the U.S. All 10 companies participate in the 3-month Stage 1, and the top 5 advance to a 2-week Silicon Valley program.